261 related articles for article (PubMed ID: 25542917)
1. Relationships of PROP Taste Phenotype, Taste Receptor Genotype, and Oral Nicotine Replacement Use.
Ahijevych K; Tepper BJ; Graham MC; Holloman C; Matcham WA
Nicotine Tob Res; 2015 Sep; 17(9):1149-55. PubMed ID: 25542917
[TBL] [Abstract][Full Text] [Related]
2. E-cigarette palatability in smokers as a function of flavorings, nicotine content and propylthiouracil (PROP) taster phenotype.
Mead EL; Duffy V; Oncken C; Litt MD
Addict Behav; 2019 Apr; 91():37-44. PubMed ID: 30470456
[TBL] [Abstract][Full Text] [Related]
3. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
[TBL] [Abstract][Full Text] [Related]
4. Relation between PROP (6-n-propylthiouracil) taster status, taste anatomy and dietary intake measures for young men and women.
Yackinous CA; Guinard JX
Appetite; 2002 Jun; 38(3):201-9. PubMed ID: 12071686
[TBL] [Abstract][Full Text] [Related]
5. Genetic sensitivity to 6-n-propylthiouracil (PROP) and hedonic responses to bitter and sweet tastes.
Drewnowski A; Henderson SA; Shore AB
Chem Senses; 1997 Feb; 22(1):27-37. PubMed ID: 9056083
[TBL] [Abstract][Full Text] [Related]
6. Heightened olfactory dysfunction and oral irritation among chronic smokers and heightened propylthiouracil (PROP) bitterness among menthol smokers.
Duffy VB; Glennon SG; Larsen BA; Rawal S; Oncken C; Litt MD
Physiol Behav; 2019 Mar; 201():111-122. PubMed ID: 30557565
[TBL] [Abstract][Full Text] [Related]
7. Randomised trial of two nicotine patch protocols distributed through a state quitline.
Burns EK; Hood NE; Goforth E; Levinson AH
Tob Control; 2016 Mar; 25(2):218-23. PubMed ID: 25416755
[TBL] [Abstract][Full Text] [Related]
8. Awareness of nicotine replacement therapy among South African smokers and their interest in using it for smoking cessation when provided for free.
Agaku IT; Ayo-Yusuf OA
Nicotine Tob Res; 2014 Apr; 16(4):500-5. PubMed ID: 24336347
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing the impact of pharmacogenomic prescribing on adherence to nicotine replacement therapy: A qualitative study of participants from a randomized controlled trial.
Wright AJ; Sutton S; Armstrong D; Aveyard P; Kinmonth AL; Marteau TM
Transl Behav Med; 2018 Jan; 8(1):18-28. PubMed ID: 29385578
[TBL] [Abstract][Full Text] [Related]
10. Motivating smokers at outdoor public smoking hotspots to have a quit attempt with a nicotine replacement therapy sample: study protocol for a randomized controlled trial.
Cheung YT; Leung JP; Cheung CK; Li WH; Wang MP; Lam TH
Trials; 2016 Jul; 17(1):355. PubMed ID: 27456342
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with nicotine replacement therapy use among hospitalised smokers.
Chui CY; Thomas D; Taylor S; Bonevski B; Abramson MJ; Paul E; Poole SG; Weeks GR; Dooley MJ; George J
Drug Alcohol Rev; 2018 May; 37(4):514-519. PubMed ID: 29411446
[TBL] [Abstract][Full Text] [Related]
12. PROP (6-n-Propylthiouracil) tasting and sensory responses to caffeine,sucrose, neohesperidin dihydrochalcone and chocolate.
Ly A; Drewnowski A
Chem Senses; 2001 Jan; 26(1):41-7. PubMed ID: 11124214
[TBL] [Abstract][Full Text] [Related]
13. Comparative Effectiveness of Smoking Cessation Medications: A National Prospective Cohort From Taiwan.
Chang PY; Lo PC; Chang HC; Hsueh KC; Tsai YW
PLoS One; 2016; 11(11):e0166992. PubMed ID: 27893843
[TBL] [Abstract][Full Text] [Related]
14. Bitter taste phenotype and body weight predict children's selection of sweet and savory foods at a palatable test-meal.
Keller KL; Olsen A; Cravener TL; Bloom R; Chung WK; Deng L; Lanzano P; Meyermann K
Appetite; 2014 Jun; 77():113-21. PubMed ID: 24607656
[TBL] [Abstract][Full Text] [Related]
15. A bitter taste in the mouth: The role of 6-n-propylthiouracil taster status and sex in food disgust sensitivity.
Ammann J; Hartmann C; Siegrist M
Physiol Behav; 2019 May; 204():219-223. PubMed ID: 30836110
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation.
Becker KM; Rose JE; Albino AP
Nicotine Tob Res; 2008 Jul; 10(7):1139-48. PubMed ID: 18629723
[TBL] [Abstract][Full Text] [Related]
17. Combination nicotine replacement therapy: strategies for initiation and tapering.
Hsia SL; Myers MG; Chen TC
Prev Med; 2017 Apr; 97():45-49. PubMed ID: 28257667
[TBL] [Abstract][Full Text] [Related]
18. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
[TBL] [Abstract][Full Text] [Related]
19. Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial.
Marteau TM; Aveyard P; Munafò MR; Prevost AT; Hollands GJ; Armstrong D; Sutton S; Hill C; Johnstone E; Kinmonth AL
PLoS One; 2012; 7(4):e35249. PubMed ID: 22509402
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
